T

TenSixteen Bio

0 followers

TenSixteen Bio is the first company to leverage somatic mosaicism and clonal hematopoiesis of indeterminate potential (CHIP) to discover and develop novel therapeutics to treat age-related diseases.

Industries

Employees

11-50

Links

This is an unverified company page

Org chart

Alex Bick
Scientific Co-founder
Andi Dhroso's profile picture
Andi Dhroso
Senior Bioinformatics Data Scientist

Teams


Offices